Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Hepatitis

Free Subscription Articles published in PLoS One Retrieve available abstracts of 139 articles: HTML format

Single Articles

January 2025
1. TEPJANTA P, Saethang T, Fujiyama K, Misaki R, et al
   In vitro and in silico analyses of amino acid substitution effects at the conserved N-linked glycosylation site in hepatitis B virus surface protein on antigenicity, immunogenicity, HBV replication and secretion.
   PLoS One. 2025;20:e0316328.
   PubMed     Abstract available
   
   
   
2. MOONEN CPB, Brouwers EEHG, Hoebe CJPA, Dukers-Muijrers NHTM, et al
   Reaching Syrian migrants through Dutch municipal registries for hepatitis B and C point-of-care testing.
   PLoS One. 2025;20:e0316726.
   PubMed     Abstract available
   
   
   
3. ADJEI-GYAMFI S, Asirifi A, Asobuno C, Korang FK, et al
   Knowledge and occupational practices of beauticians and barbers in the transmission of viral hepatitis: A mixed-methods study in Volta Region of Ghana.
   PLoS One. 2025;20:e0306961.
   PubMed     Abstract available
   
   
   
4. PATIL A, Vidhate P, Patil S, Rao A, et al
   Looking back into the Hepatitis C Virus epidemic dynamics from Unnao, India through phylogenetic approach.
   PLoS One. 2025;20:e0317705.
   PubMed     Abstract available
   
   
   
5. TOY M, Hutton D, Conners EE, Pham H, et al
   Cost-effectiveness of monitoring and liver cancer surveillance among patients with inactive chronic hepatitis B.
   PLoS One. 2025;20:e0313898.
   PubMed     Abstract available
   
   
   
6. MUTAMBO IN, Bett B, Bukachi SA
   "Without a man's decision, nothing works": Building resilience to Rift Valley fever in pastoralist communities in Isiolo Kenya.
   PLoS One. 2025;20:e0316015.
   PubMed     Abstract available
   
   
   
7. KASONGAMULILO CC, Syakalima M, Saasa N, Kainga H, et al
   Evidence of human exposure and associated risk factors to Rift Valley fever in selected districts of Central and Western Zambia.
   PLoS One. 2025;20:e0309288.
   PubMed     Abstract available
   
   
   
8. ZUBAIR S, Parvaiz F, Abualait T, Al-Regaiey K, et al
   Computational design of multi-epitope vaccine against Hepatitis C Virus infection using immunoinformatics techniques.
   PLoS One. 2025;20:e0317520.
   PubMed     Abstract available
   
   
   
9. 
   Expression of Concern: Chaperone-Mediated Autophagy Targets IFNAR1 for Lysosomal Degradation in Free Fatty Acid Treated HCV Cell Culture.
   PLoS One. 2025;20:e0319262.
   PubMed    
   
   
   
10. YE W, Ding Y, Li M, Tian Z, et al
    Drug-induced autoimmune-like hepatitis: A disproportionality analysis based on the FAERS database.
    PLoS One. 2025;20:e0317680.
    PubMed     Abstract available
    
    
    
11. VAN RENNE N, Vanwolleghem T
    Detection of hepatitis B virus mRNA from single cell RNA sequencing data without prior knowledge.
    PLoS One. 2025;20:e0314060.
    PubMed     Abstract available
    
    
    
12. ELIAH DT, Chamba NG, Sadiq AM, Mwasamwaja AO, et al
    Seroprevalence and associated factors for hepatitis B and hepatitis C viral infection among patients with diabetes mellitus in Northern Tanzania.
    PLoS One. 2025;20:e0319198.
    PubMed     Abstract available
    
    
    
13. TORIU N, Sato Y, Kamimura H, Yoshikawa T, et al
    Aligning cellular and molecular components in age-dependent tertiary lymphoid tissues of kidney and liver.
    PLoS One. 2025;20:e0311193.
    PubMed     Abstract available
    
    
    
14. NOSAKA T, Naito T, Akazawa Y, Takahashi K, et al
    Identification of novel antiviral host factors by functional gene expression analysis using in vitro HBV infection assay systems.
    PLoS One. 2025;20:e0314581.
    PubMed     Abstract available
    
    
    
15. XUE M, Wu C, Liu K, Lu Q, et al
    Time series analysis and scaling law characteristics of viral hepatitis from 2004 to 2023 in Zhejiang Province, China.
    PLoS One. 2025;20:e0319642.
    PubMed     Abstract available
    
    
    
16. 
    Expression of Concern: Impaired expression of type I and type II interferon receptors in HCV-associated chronic liver disease and liver cirrhosis.
    PLoS One. 2025;20:e0320610.
    PubMed    
    
    
    
17. BERHANU L, Desye B, Daba C, Berihun G, et al
    Seroprevalence and risk factors of hepatitis B virus infection among healthcare workers in Africa: A systematic review and meta-analysis.
    PLoS One. 2025;20:e0319986.
    PubMed     Abstract available
    
    
    
18. LAMICHHANE R, Pathak ID, Pathak BD, Adhikari P, et al
    Low Hepatitis B vaccination rates among medical students in South Asia: A systematic review and meta-analysis.
    PLoS One. 2025;20:e0320330.
    PubMed     Abstract available
    
    
    
19. PAWLOWSKI T, Radkowski M, Perlejewski K, Szymanska B, et al
    Direct-acting antivirals (DAA) positively affect depression and cognitive function in patients with chronic hepatitis C.
    PLoS One. 2025;20:e0320221.
    PubMed     Abstract available
    
    
    
20. LI J, He J, Yang G, Cao Z, et al
    Influencing factors of HCV testing willingness among men who have sex with men in China: A structural equation modeling analysis.
    PLoS One. 2025;20:e0321469.
    PubMed     Abstract available
    
    
    
21. DAS N, Hossain MB, Adhikary A, Raha AD, et al
    Enlightened prognosis: Hepatitis prediction with an explainable machine learning approach.
    PLoS One. 2025;20:e0319078.
    PubMed     Abstract available
    
    
    
22. VO LT, Phan DQ, Tran HG, Nguyen LTP, et al
    Hepatitis B vaccine coverage in health care students: a cross-sectional study in Vietnam.
    PLoS One. 2025;20:e0320860.
    PubMed     Abstract available
    
    
    
23. BAKIC M, Stevanovic J, Milic M, Galic I, et al
    Factors associated with the prevalence of viral hepatitis B and C among prisoners: Results of two consecutive national surveys in Montenegro.
    PLoS One. 2025;20:e0321464.
    PubMed     Abstract available
    
    
    
24. OROTTA M, Munseri P, Massawe RV, Orotta GM, et al
    Hepatitis B virus: Prevalence, vaccination coverage and immune responses to immunization among healthcare workers at Muhimbili National Hospital.
    PLoS One. 2025;20:e0321623.
    PubMed     Abstract available
    
    
    
25. FOSU PK, Hoor GT, Adjei CA, Atibila F, et al
    Prevalence of Hepatitis C viral infection in Ghana: A systematic review and meta-analysis protocol.
    PLoS One. 2025;20:e0321483.
    PubMed     Abstract available
    
    
    
26. AWADELKARIM KE, Osman NAM, Eleragi AMS, Nail AMA, et al
    Chronic active and chronic inactive hepatitis B virus infection: Comparative study of genetic polymorphism and blood profile measures.
    PLoS One. 2025;20:e0322268.
    PubMed     Abstract available
    
    
    
27. NAMATOVU J, Lule P, Asindu M, Campbell ZA, et al
    Gender roles in ruminant disease management in Uganda: Implications for the control of peste des petits ruminants and Rift Valley fever.
    PLoS One. 2025;20:e0320991.
    PubMed     Abstract available
    
    
    
28. BAHARUDIN MH, Mokhtar SA, Azman AZF, Mohd Nazan AIN, et al
    Utilizing Theory of Planned Behaviour to increase intention to participate in hepatitis C treatment therapy among Methadone maintenance therapy clients (MMT) in Malaysia: A cluster randomised control trial.
    PLoS One. 2025;20:e0324718.
    PubMed     Abstract available
    
    
    
29. SEGHIERI C, Ceccarelli L, Tortu C, Tavoschi L, et al
    Evaluating the effectiveness of a population-level health intervention to increment HCV treatment coverage in tuscany region, Italy: An interrupted time series analysis.
    PLoS One. 2025;20:e0306733.
    PubMed     Abstract available
    
    
    
30. CAM HUONG NT, Van Tri D, Luan NH, Thinh NH, et al
    Seroprevalence of hepatitis A virus infection in urban and rural areas in Vietnam.
    PLoS One. 2025;20:e0323139.
    PubMed     Abstract available
    
    
    
31. BHAT KD, Bhattacharya H, Jayaraman Y, Kanungo S, et al
    Hepatitis B virus infection among children aged 1- 5 years of Mayurbhanj district (Odisha), India: A prospective study protocol.
    PLoS One. 2025;20:e0317621.
    PubMed     Abstract available
    
    
    
32. ASSOAH E, Yar DD, Amissah-Reynolds PK, Balali GI, et al
    Co-infections and risk factors of Toxoplasma gondii infection among pregnant women in Ghana: A facility-based cross-sectional study.
    PLoS One. 2025;20:e0324950.
    PubMed     Abstract available
    
    
    
33. PRAGUYLERTLUCK W, Kaewdech A, Chamroonkul N, Piratvisuth T, et al
    Effect of switching from prior Nucleos(t)ide Analogue(s) to Tenofovir alafenamide on lipid profile and cardiovascular risk in patients with Chronic Hepatitis B.
    PLoS One. 2025;20:e0324897.
    PubMed     Abstract available
    
    
    
34. WOYTOWICH D, McIntyre AF, Solomon H, Hanunka B, et al
    Local data for local programming: Results from an HIV biobehavioral survey among people who inject drugs in Livingstone, Lusaka, and Ndola, Zambia, 2021.
    PLoS One. 2025;20:e0323919.
    PubMed     Abstract available
    
    
    
35. MOTSHOSI P, Phinius BB, Jongman M, Baruti K, et al
    Optimization of dried blood spot for hepatitis B virus surface antibody quantification.
    PLoS One. 2025;20:e0304931.
    PubMed     Abstract available
    
    
    
36. MA X, Huang T, Song Y, Pan H, et al
    Bioinformatics and system biology approach to discover the common pathogenetic processes between COVID-19 and chronic hepatitis B.
    PLoS One. 2025;20:e0323708.
    PubMed     Abstract available
    
    
    
37. KERR CM, Proctor-Roser MA, Parthasarathy S, O'Connor JJ, et al
    IFN-gamma signaling is required for the efficient replication of murine hepatitis virus (MHV) strain JHM in the brains of infected mice.
    PLoS One. 2025;20:e0317482.
    PubMed     Abstract available
    
    
    
38. PARK YJ, Yi KY, Woo HY, Heo J, et al
    Risk of HBV reactivation in HBV/HCV-co-infected HCV-treated patients: A single-center study.
    PLoS One. 2025;20:e0324019.
    PubMed     Abstract available
    
    
    January 2024
39. DARVISHI-KHEZRI H, Karami H, Naderisorki M, Ghazaiean M, et al
    Two risk factors for hypozincemia in diabetic beta-thalassemia patients: Hepatitis C and deferasirox.
    PLoS One. 2024;19:e0284267.
    PubMed     Abstract available
    
    
    
40. HOSKING K, De Santis T, Vintour-Cesar E, Wilson PM, et al
    "Putting the power back into community": A mixed methods evaluation of a chronic hepatitis B training course for the Aboriginal health workforce of Australia's Northern Territory.
    PLoS One. 2024;19:e0288577.
    PubMed     Abstract available
    
    
    
41. SHIBABAW AA, Tegegne MD, Walle AD, Wubante SM, et al
    Information seeking behavior on hepatitis B virus, and its associated factors among pregnant women at teaching and specialized hospitals, Northwest Ethiopia: A cross-sectional study.
    PLoS One. 2024;19:e0286755.
    PubMed     Abstract available
    
    
    
42. KALIBATAS V, Kalibatiene L, Imashpayev D
    Blood donations and donors' profile in Lithuania: Trends for coming back after the COVID-19 outbreak.
    PLoS One. 2024;19:e0297580.
    PubMed     Abstract available
    
    
    
43. KENFACK-MOMO R, Ngounoue MD, Kenmoe S, Takuissu GR, et al
    Global epidemiology of hepatitis C virus in dialysis patients: A systematic review and meta-analysis.
    PLoS One. 2024;19:e0284169.
    PubMed     Abstract available
    
    
    
44. MODIYINJI AF, Tankeu LTA, Monamele CG, Yifomnjou Moumbeket MH, et al
    Hepatitis E virus infections among patients with acute febrile jaundice in two regions of Cameroon: First molecular characterization of hepatitis E virus genotype 4.
    PLoS One. 2024;19:e0298723.
    PubMed     Abstract available
    
    
    
45. ABER JO, Bongomin F, Opio SL, Ochola E, et al
    Hepatitis B vaccine uptake and associated factors among adults of Gulu city in Northern Uganda: A community-based cross-sectional study.
    PLoS One. 2024;19:e0297617.
    PubMed     Abstract available
    
    
    
46. DZUDZOR B, Nsowah KK, Agyemang S, Vento S, et al
    Overt and occult hepatitis B virus infection detected among chronic kidney disease patients on haemodialysis at a Tertiary Hospital in Ghana.
    PLoS One. 2024;19:e0290917.
    PubMed     Abstract available
    
    
    
47. CAMA E, Brener L, Broady T, Horwitz R, et al
    Hepatitis B screening and knowledge among Chinese and Vietnamese students in Australia.
    PLoS One. 2024;19:e0299224.
    PubMed     Abstract available
    
    
    
48. NOMBOT-YAZENGUET MPM, Modiyinji AF, Tricou V, Manirakiza A, et al
    Investigating animal reservoirs for hepatitis E virus in Bangui, Central African Republic.
    PLoS One. 2024;19:e0300608.
    PubMed     Abstract available
    
    
    
49. YEN YH, Kee KM, Hu TH, Tsai MC, et al
    Hepatitis B virus-related hepatocellular carcinoma has superior overall survival compared with other etiologies.
    PLoS One. 2024;19:e0290523.
    PubMed     Abstract available
    
    
    
50. TEPJANTA P, Fujiyama K, Misaki R, Kimkong I, et al
    The N-linked glycosylation modifications in the hepatitis B surface protein impact cellular autophagy, HBV replication, and HBV secretion.
    PLoS One. 2024;19:e0299403.
    PubMed     Abstract available
    
    
    
51. VECHI HT, Bay MB, Freitas CHS, Sant'anna JGFC, et al
    Factors associated with hepatitis A susceptibility among men who have sex with men using HIV pre-exposure prophylaxis in Northeastern Brazil: A cross-sectional study.
    PLoS One. 2024;19:e0301397.
    PubMed     Abstract available
    
    
    
52. DEBSIKREO N, Mankreo BL, Moukenet A, Ouangkake M, et al
    Prevalence of hepatitis B virus infection and its associated factors among students in N'Djamena, Chad.
    PLoS One. 2024;19:e0273589.
    PubMed     Abstract available
    
    
    
53. TADESSE K, Ayalew G, Million Y, Gelaw A, et al
    Hepatitis B and hepatitis C virus infections and associated factors among prisoners in Gondar City, Northwest Ethiopia.
    PLoS One. 2024;19:e0301973.
    PubMed     Abstract available
    
    
    
54. SENOO-DOGBEY VE, Anto F, Quansah R, Danso-Appiah A, et al
    Completion of three-dose hepatitis B vaccination cycle and associated factors among health care workers in the Greater Accra Region of Ghana.
    PLoS One. 2024;19:e0298771.
    PubMed     Abstract available
    
    
    
55. DUCHEN D, Clipman SJ, Vergara C, Thio CL, et al
    A hepatitis B virus (HBV) sequence variation graph improves alignment and sample-specific consensus sequence construction.
    PLoS One. 2024;19:e0301069.
    PubMed     Abstract available
    
    
    
56. KIMBALL S, Reynoso M, McKnight C, Des Jarlais D, et al
    Hepatitis C treatment outcomes among people who inject drugs experiencing unstable versus stable housing: Systematic review and meta-analysis.
    PLoS One. 2024;19:e0302471.
    PubMed     Abstract available
    
    
    
57. WENDELBOE AM, Naqvi OH, Williams M, Hollen H, et al
    Opioid and other drug use and drug-related mortality as indicators of Hepatitis C and Human Immunodeficiency Virus in Oklahoma.
    PLoS One. 2024;19:e0301442.
    PubMed     Abstract available
    
    
    
58. BASIMANE-BISIMWA P, Koyaweda GW, Ngaiganam E, Vickos U, et al
    Seroprevalence and molecular characterization of viral hepatitis and HIV co-infection in the Central African Republic.
    PLoS One. 2024;19:e0291155.
    PubMed     Abstract available
    
    
    
59. ANANCHUENSOOK P, Suksawatamnauy S, Thaimai P, Sriphoosanaphan S, et al
    Correction: The association between vitamin D receptor polymorphism and phases of chronic hepatitis B infection in HBV carriers in Thailand.
    PLoS One. 2024;19:e0303545.
    PubMed     Abstract available
    
    
    
60. HAGOS YM, Yalew GT, Meles HN, Tsegay E, et al
    Hepatitis B and C viral coinfection and associated factors among HIV-positive patients attending ART clinics of Afar regional state, northeast Ethiopia.
    PLoS One. 2024;19:e0302453.
    PubMed     Abstract available
    
    
    
61. GOLAM RM, Khalil MAF, Shaker OG, Ahmed TI, et al
    The clinical significance of long non-coding RNAs MALAT1 and CASC2 in the diagnosis of HCV-related hepatocellular carcinoma.
    PLoS One. 2024;19:e0303314.
    PubMed     Abstract available
    
    
    
62. PEWKLIANG Y, Thongsri P, Suthivanich P, Thongbaiphet N, et al
    Immortalized hepatocyte-like cells: A competent hepatocyte model for studying clinical HCV isolate infection.
    PLoS One. 2024;19:e0303265.
    PubMed     Abstract available
    
    
    
63. MIURA M, Nishino M, Kawaguchi K, Li S, et al
    Programmed cell death-1 is involved with peripheral blood immune cell profiles in patients with hepatitis C virus antiviral therapy.
    PLoS One. 2024;19:e0299424.
    PubMed     Abstract available
    
    
    
64. WANG L, Liao F, Yang L, Jiang L, et al
    KLRG1-expressing CD8+ T cells are exhausted and polyfunctional in patients with chronic hepatitis B.
    PLoS One. 2024;19:e0303945.
    PubMed     Abstract available
    
    
    
65. GEDEFIE A, Debash H, Asmamaw S, Getaneh FB, et al
    Epidemiology of an overlapping and parallel infection of Sexually Transmitted Infections among pregnant women in North-east Ethiopia: Its implication for prevention of mother to child transmission.
    PLoS One. 2024;19:e0300149.
    PubMed     Abstract available
    
    
    
66. SABIN L, Haghparast-Bidgoli H, Miller F, Saville N, et al
    A systematic review of barriers and facilitators to antenatal screening for HIV, syphilis or hepatitis B in Asia: Perspectives of pregnant women, their relatives and health care providers.
    PLoS One. 2024;19:e0300581.
    PubMed     Abstract available
    
    
    
67. PULLARKAT S, Black G, Bleakley M, Buenrostro D, et al
    qPCR assay for detection of Woodchuck Hepatitis Virus Post-Transcriptional Regulatory Elements from CAR-T and TCR-T cells in fresh and formalin-fixed tissue.
    PLoS One. 2024;19:e0303057.
    PubMed     Abstract available
    
    
    
68. HAN J, Jang KL
    All-trans retinoic acid downregulates HBx levels via E6-associated protein-mediated proteasomal degradation to suppress hepatitis B virus replication.
    PLoS One. 2024;19:e0305350.
    PubMed     Abstract available
    
    
    
69. CHI G, Pei J, Li X
    Inflammatory bowel disease and risk of autoimmune hepatitis: A univariable and multivariable Mendelian randomization study.
    PLoS One. 2024;19:e0305220.
    PubMed     Abstract available
    
    
    
70. SALU OB, Akinbamiro TF, Orenolu RM, Ishaya OD, et al
    Detection of hepatitis viruses in suspected cases of Viral Haemorrhagic Fevers in Nigeria.
    PLoS One. 2024;19:e0305521.
    PubMed     Abstract available
    
    
    
71. NDZIE ONDIGUI JL, Mafopa Goumkwa N, Lobe C, Wandji B, et al
    Prevalence and risk factors of transmission of hepatitis delta virus in pregnant women in the Center Region of Cameroon.
    PLoS One. 2024;19:e0287491.
    PubMed     Abstract available
    
    
    
72. GURAV YK, Bagepally BS, Chitpim N, Sobhonslidsuk A, et al
    Cost-effective analysis of hepatitis A vaccination in Kerala state, India.
    PLoS One. 2024;19:e0306293.
    PubMed     Abstract available
    
    
    
73. FARHAN M, Shah Z, Ling Z, Shah K, et al
    Global dynamics and computational modeling for analyzing and controlling Hepatitis B: A novel epidemic approach.
    PLoS One. 2024;19:e0304375.
    PubMed     Abstract available
    
    
    
74. NAM DE, Park SJ, Omole S, Um E, et al
    Activated Gab1 drives hepatocyte proliferation and anti-apoptosis in liver fibrosis via potential involvement of the HGF/c-Met signaling axis.
    PLoS One. 2024;19:e0306345.
    PubMed     Abstract available
    
    
    
75. SALIA E, Nartey YA, Djankpa FT, Pappoe F, et al
    Prevalence of occult hepatitis B infection among treatment-naive persons living with HIV in Ghana.
    PLoS One. 2024;19:e0305862.
    PubMed     Abstract available
    
    
    
76. ZEZIULIN O, Kornilova M, Deac A, Morozova O, et al
    Modes of HIV transmission among young women and their sexual partners in Ukraine.
    PLoS One. 2024;19:e0305072.
    PubMed     Abstract available
    
    
    
77. BASIMANE BISIMWA P, Koyaweda GW, Bihehe Masemo D, Ayagirwe RBB, et al
    High prevalence of hepatitis B and HIV among women survivors of sexual violence in South Kivu province, eastern Democratic Republic of Congo.
    PLoS One. 2024;19:e0292473.
    PubMed     Abstract available
    
    
    
78. SIAW ADJ, Amugsi J, Owusu-Konadu MAA, Drah ST, et al
    Prevalence and risk factors of Hepatitis C virus infection in the Upper East Region of Ghana; a community-based cross-sectional study.
    PLoS One. 2024;19:e0306292.
    PubMed     Abstract available
    
    
    
79. YIRSAW BG, Agimas MC, Alemu GG, Tesfie TK, et al
    Prevalence of Hepatitis B virus infection and its determinants among pregnant women in East Africa: Systematic review and Meta-analysis.
    PLoS One. 2024;19:e0307102.
    PubMed     Abstract available
    
    
    
80. GIKUNYU CW, Mbogori E, Kwena A, Maiyoh GK, et al
    Prevalence of HBV genotypes among patients attending Moi Teaching and Referral Hospital liver clinic.
    PLoS One. 2024;19:e0305753.
    PubMed     Abstract available
    
    
    
81. KITIL GW, Dubale AT, Shibabaw AA, Chereka AA, et al
    Practices for preventing Hepatitis B infection among health science students in Ethiopia: Systematic review and meta-analysis.
    PLoS One. 2024;19:e0306965.
    PubMed     Abstract available
    
    
    
82. YOUNES N, Chemaitelly H, Nizamuddin PB, Al-Hamad T, et al
    Prevalence of hepatitis A virus among migrant workers in Qatar: A national study.
    PLoS One. 2024;19:e0306753.
    PubMed     Abstract available
    
    
    
83. ZEHRA A, Jamil S, Farman M, Nisar KS, et al
    Modeling and analysis of Hepatitis B dynamics with vaccination and treatment with novel fractional derivative.
    PLoS One. 2024;19:e0307388.
    PubMed     Abstract available
    
    
    
84. LAREBO YM, Anshebo AA, Abdo RA, Behera SK, et al
    Prevalence of hepatitis B virus infection among pregnant women in Africa: A systematic review and meta-analysis.
    PLoS One. 2024;19:e0305838.
    PubMed     Abstract available
    
    
    
85. ATANAW T, Girmay G, Zemene A, Assefa M, et al
    Seroprevalence of hepatitis B and C viruses and some possible associated factors among cancer patients at the Oncology Treatment Center, Gondar, Northwest Ethiopia: A cross-sectional study.
    PLoS One. 2024;19:e0308161.
    PubMed     Abstract available
    
    
    
86. ANTENEH DE, Taye EB, Seyoum AT, Abuhay AE, et al
    Seroprevalence of HIV, HBV, and syphilis co-infections and associated factors among pregnant women attending antenatal care in Amhara regional state, northern Ethiopia: A hospital-based cross-sectional study.
    PLoS One. 2024;19:e0308634.
    PubMed     Abstract available
    
    
    
87. 
    Retraction: Interferon and Ribavirin Combination Treatment Synergistically Inhibit HCV Internal Ribosome Entry Site Mediated Translation at the Level of Polyribosome Formation.
    PLoS One. 2024;19:e0308579.
    PubMed    
    
    
    
88. DANIELS J, Nartey YA, Djankpa F, Simpore J, et al
    Characteristics and antiviral treatment eligibility of patients diagnosed with hepatitis B at a teaching hospital in Ghana: Implications for prevention and management.
    PLoS One. 2024;19:e0302086.
    PubMed     Abstract available
    
    
    
89. KIM N, Kim S, Choi JR, Park Y, et al
    Evaluation of autoimmune liver disease antibodies in hepatitis patients.
    PLoS One. 2024;19:e0307285.
    PubMed     Abstract available
    
    
    
90. DOS MUCHANGOS V, Chambal L, Nilsson C, Sevene E, et al
    HIV and hepatitis B virus co-infection in Mozambique: Policy review and health professionals' knowledge and practices.
    PLoS One. 2024;19:e0301305.
    PubMed     Abstract available
    
    
    
91. MANGALA C, Maulot-Bangola D, Moutsinga A, Okolongo-Mayani SC, et al
    Prevalence and factors associated with transfusion-transmissible infections (HIV, HBV, HCV and Syphilis) among blood donors in Gabon: Systematic review and meta-analysis.
    PLoS One. 2024;19:e0307101.
    PubMed     Abstract available
    
    
    
92. LEE CSJ, Mateu-Gelabert P, Melendez YA, Fong C, et al
    Reduced injection risk behavior with co-located hepatitis C treatment at a syringe service program: The accessible care model.
    PLoS One. 2024;19:e0308102.
    PubMed     Abstract available
    
    
    
93. GUURE C, Dery S, Baptista da Silva C, Asamoah-Adu C, et al
    Situational assessment and epidemiology of HIV, HBV and HCV among people who use and inject drugs in Ghana.
    PLoS One. 2024;19:e0305923.
    PubMed     Abstract available
    
    
    
94. KIM MN, Kim BK, Cho H, Goh MJ, et al
    Similar recurrence after curative treatment of HBV-related HCC, regardless of HBV replication activity.
    PLoS One. 2024;19:e0307712.
    PubMed     Abstract available
    
    
    
95. MAZUMDER H, Hossain MF, Shrestha P, Mahmud S, et al
    Prevalence and associated risk factors of current hepatitis C infection among U.S. general population and injection drug users aged 20-59 years: NHANES 2009-2018.
    PLoS One. 2024;19:e0309345.
    PubMed     Abstract available
    
    
    
96. WANG HW, Wang YC, Huang YT, Jiang MY, et al
    All-cause and cause-specific mortality risk among men and women with hepatitis C virus infection.
    PLoS One. 2024;19:e0309819.
    PubMed     Abstract available
    
    
    
97. LU Y, Mohammad NS, Lee J, Aranyos AM, et al
    Berberine potentiates liver inflammation and fibrosis in the PI*Z hAAT transgenic murine model.
    PLoS One. 2024;19:e0310524.
    PubMed     Abstract available
    
    
    
98. PHYO Z, Ko K, Ouoba S, Sugiyama A, et al
    Intermediate hepatitis C virus (HCV) endemicity and its genotype distribution in Myanmar: A systematic review and meta-analysis.
    PLoS One. 2024;19:e0307872.
    PubMed     Abstract available
    
    
    
99. CHIU I, Cano D, Leathers M, Turner CM, et al
    HIV and hepatitis C virus infection and co-infection among trans women in San Francisco, 2020.
    PLoS One. 2024;19:e0307990.
    PubMed     Abstract available
    
    
    
100. MLEWA M, Nyawale HA, Henerico S, Mangowi I, et al
     Hepatitis B infection: Evaluation of demographics and treatment of chronic hepatitis B infection in Northern-western Tanzania.
     PLoS One. 2024;19:e0309314.
     PubMed     Abstract available
     
     
     
101. MULLER DL, Stuckey H, Flores ES, Wang L, et al
     Primary care physicians' perspectives on adults with diabetes and the recommended hepatitis B vaccine: A qualitative study.
     PLoS One. 2024;19:e0312168.
     PubMed     Abstract available
     
     
     
102. ALARIDAH N, Jereisat RA, Abu-Mutaw S, Abuhani HO, et al
     Knowledge, attitude, and practices toward Hepatitis B infection among hemodialysis patients: A nationwide study in Jordan.
     PLoS One. 2024;19:e0312226.
     PubMed     Abstract available
     
     
     
103. MBENCHO MN, Hafza N, Cao LC, Mingo VN, et al
     Incidence of Occult Hepatitis B Infection (OBI) and hepatitis B genotype characterization among blood donors in Cameroon.
     PLoS One. 2024;19:e0312126.
     PubMed     Abstract available
     
     
     
104. ASTLEY J, Saralamba S, Poovorawan K, White LJ, et al
     Population and transmission dynamics model to determine WHO targets for eliminating Hepatitis C virus in Thailand.
     PLoS One. 2024;19:e0309313.
     PubMed     Abstract available
     
     
     
105. PASTOR F, Charles E, Di Vona C, Chapelle M, et al
     The dual-specificity kinase DYRK1A interacts with the Hepatitis B virus genome and regulates the production of viral RNA.
     PLoS One. 2024;19:e0311655.
     PubMed     Abstract available
     
     
     
106. EBRAHIMI R, Masouri MM, Salehi Amniyeh Khozani AA, Ramadhan Hussein D, et al
     Safety and efficacy of fecal microbiota transplantation for viral diseases: A systematic review of clinical trials.
     PLoS One. 2024;19:e0311731.
     PubMed     Abstract available
     
     
     
107. 
     Retraction: SH2 Modified STAT1 Induces HLA-I Expression and Improves IFN-gamma Signaling in IFN-alpha Resistant HCV Replicon Cells.
     PLoS One. 2024;19:e0313111.
     PubMed    
     
     
     
108. JIANG J, Shiels MS, Rivera D, Ghany MG, et al
     Trends in hepatocellular carcinoma and viral hepatitis treatment in older Americans.
     PLoS One. 2024;19:e0307746.
     PubMed     Abstract available
     
     
     
109. ONDONDO RO, Muthusi J, Oramisi V, Kimani D, et al
     Prevalence of hepatitis B virus infection in Kenya: A study nested in the Kenya Population-based HIV Impact Assessment 2018.
     PLoS One. 2024;19:e0310923.
     PubMed     Abstract available
     
     
     
110. ZHANG C, Ma Q, Wang W, Song H, et al
     Increased QPCT gene expression by the hepatitis B virus promotes HBV replication.
     PLoS One. 2024;19:e0312773.
     PubMed     Abstract available
     
     
     
111. GIRMAY G, Bewket G, Amare A, Angelo AA, et al
     Seroprevalence of viral hepatitis B and C infections among healthcare workers in Ethiopia: A systematic review and meta-analysis.
     PLoS One. 2024;19:e0312959.
     PubMed     Abstract available
     
     
     
112. KANOKUDOM S, Poovorawan K, Nilyanimit P, Suntronwong N, et al
     Comparison of anti-HCV combined with HCVcAg (Elecsys HCV Duo immunoassay) and anti-HCV rapid test followed by HCV RNA analysis using qRT-PCR to identify active infection for treatment.
     PLoS One. 2024;19:e0313771.
     PubMed     Abstract available
     
     
     
113. LAMICHHANE R, Adhikari P, Pathak BD, Rai A, et al
     Knowledge, attitude, and practice towards Hepatitis B and vaccination status of pre-clinical medical students at Sylhet Women's Medical College, Bangladesh.
     PLoS One. 2024;19:e0310443.
     PubMed     Abstract available
     
     
     
114. SHAN J, Huang B, Xin Y, Li R, et al
     The clinical characteristics and SARS-CoV-2 infection in children of acute hepatitis with unknown aetiology: A meta-analysis and systematic review.
     PLoS One. 2024;19:e0311772.
     PubMed     Abstract available
     
     
     
115. NAULLY PG, Tan MI, Nugrahapraja H, Artarini AA, et al
     Design of multi-epitope-based therapeutic vaccine candidates from HBc and HBx proteins of hepatitis B virus using reverse vaccinology and immunoinformatics approaches.
     PLoS One. 2024;19:e0313269.
     PubMed     Abstract available
     
     
     
116. HONGJAISEE S, Khamduang W, Kham-Kjing N, Ngo-Giang-Huong N, et al
     Seroprevalence and associated factors of HIV, syphilis, hepatitis B, and hepatitis C infections among sex workers in Chiangmai, Thailand during easing of COVID-19 lockdown measures.
     PLoS One. 2024;19:e0316668.
     PubMed     Abstract available
     
     
     January 2023
117. EJAZ S, Paracha RZ, Ejaz S, Jamal Z, et al
     Antibody designing against IIIabc junction (JIIIabc) of HCV IRES through affinity maturation; RNA-Antibody docking and interaction analysis.
     PLoS One. 2023;18:e0291213.
     PubMed     Abstract available
     
     
     
118. YOSHIDA Y, Atsukawa M, Kondo C, Kitamura M, et al
     A novel formula used for predicting hepatocellular carcinoma after the achievement of sustained virologic response by direct-acting antivirals in patients with chronic hepatitis C.
     PLoS One. 2023;18:e0292019.
     PubMed     Abstract available
     
     
     
119. ZHANG Z, Liang G, Chang K
     Stationary distribution of a reaction-diffusion hepatitis B virus infection model driven by the Ornstein-Uhlenbeck process.
     PLoS One. 2023;18:e0292073.
     PubMed     Abstract available
     
     
     
120. 
     Expression of Concern: The HBx Oncoprotein of Hepatitis B Virus Deregulates the Cell Cycle by Promoting the Intracellular Accumulation and Re-Compartmentalization of the Cellular Deubiquitinase USP37.
     PLoS One. 2023;18:e0293102.
     PubMed    
     
     
     
121. BEDASSA BB, Ebo GG, Yimam JA, Tura JB, et al
     Correction: Prevalence and factors associated with hepatitis B and C virus infections among female Sex workers in Ethiopia: Results of the national biobehavioral Survey, 2020.
     PLoS One. 2023;18:e0292824.
     PubMed     Abstract available
     
     
     
122. GOINS EC, Wein LE, Watkins VY, Campbell AIK, et al
     Maternal and neonatal outcomes in patients with hepatitis C and intrahepatic cholestasis of pregnancy: The sum of the parts.
     PLoS One. 2023;18:e0293030.
     PubMed     Abstract available
     
     
     
123. HOOD RB, Miller WC, Shoben A, Harris RE, et al
     Maternal hepatitis C virus infection and three adverse maternal outcomes in the United States.
     PLoS One. 2023;18:e0291994.
     PubMed     Abstract available
     
     
     
124. BUTT AIK, Imran M, Aslam J, Batool S, et al
     Computational analysis of control of hepatitis B virus disease through vaccination and treatment strategies.
     PLoS One. 2023;18:e0288024.
     PubMed     Abstract available
     
     
     
125. GNANAPANDITHAN K, Ghali MP
     Self-awareness of hepatitis C infection in the United States: A cross-sectional study based on the National Health Nutrition and Examination Survey.
     PLoS One. 2023;18:e0293315.
     PubMed     Abstract available
     
     
     
126. ANGELO L, Vaillant A, Blanchet M, Labonte P, et al
     Pangenomic antiviral effect of REP 2139 in CRISPR/Cas9 engineered cell lines expressing hepatitis B virus surface antigen.
     PLoS One. 2023;18:e0293167.
     PubMed     Abstract available
     
     
     
127. NAQID IA, Mosa AA, Ibrahim SV, Ibrahim NH, et al
     Hepatitis B vaccination status and knowledge, attitude, and practice towards Hepatitis B virus among medical sciences students: A cross-sectional study.
     PLoS One. 2023;18:e0293822.
     PubMed     Abstract available
     
     
     
128. SAGOE KWC, Atuahene K, Ayiku ANA, Pappoe-Ashong PJ, et al
     Hepatitis B and human immunodeficiency virus infections within correctional facilities in Ghana.
     PLoS One. 2023;18:e0293009.
     PubMed     Abstract available
     
     
     
129. LANGAT BK, Ochwedo KO, Borlang J, Osiowy C, et al
     Genetic diversity, haplotype analysis, and prevalence of Hepatitis B virus MHR mutations among isolates from Kenyan blood donors.
     PLoS One. 2023;18:e0291378.
     PubMed     Abstract available
     
     
     
130. PRINSENBERG T, Illidge J, Zantkuijl P, Bedert M, et al
     Correction: Usability, acceptability, and self-reported impact of an innovative hepatitis C risk reduction intervention for men have sex with men: A mixed methods study.
     PLoS One. 2023;18:e0295455.
     PubMed     Abstract available
     
     
     
131. FONGWEN NT, Nchafack A, Rohan H, Ong JJ, et al
     Role and effectiveness of telephone hotlines in outbreak response in Africa: A systematic review and meta-analysis.
     PLoS One. 2023;18:e0292085.
     PubMed     Abstract available
     
     
     
132. QI M, Santos H, Pinheiro P, McGuinness DL, et al
     Demographic and socioeconomic determinants of access to care: A subgroup disparity analysis using new equity-focused measurements.
     PLoS One. 2023;18:e0290692.
     PubMed     Abstract available
     
     
     
133. KYEGOMBE N, Ajibola G, Sakoi-Mosetlhi M, Rebatenne T, et al
     Correction: Youth and healthcare workers' perspectives on the feasibility and acceptability of self-testing for HIV, Hepatitis and Syphilis among young people: Qualitative findings from a pilot study in Gaborone, Botswana.
     PLoS One. 2023;18:e0295779.
     PubMed     Abstract available
     
     
     
134. WANG B, Kaufmann B, Mogler C, Zhong S, et al
     Hepatocellular Brg1 promotes CCl4-induced liver inflammation, ECM accumulation and fibrosis in mice.
     PLoS One. 2023;18:e0294257.
     PubMed     Abstract available
     
     
     
135. ANWAR T, Ismail S, Parvaiz F, Abbasi SW, et al
     Computational design of experimentally validated multi-epitopes vaccine against hepatitis E virus: An immunological approach.
     PLoS One. 2023;18:e0294663.
     PubMed     Abstract available
     
     
     
136. YE J, Sun Y, Li J, Lu X, et al
     Distribution pattern, molecular transmission networks, and phylodynamic of hepatitis C virus in China.
     PLoS One. 2023;18:e0296053.
     PubMed     Abstract available
     
     
     
137. WURCEL AG, Guardado R, Grussing ED, Koutoujian PJ, et al
     Racial differences in testing for infectious diseases: An analysis of jail intake data.
     PLoS One. 2023;18:e0288254.
     PubMed     Abstract available
     
     
     
138. HOGAN S, Page A, Dixit S, McBride KA, et al
     HBV prevalence in Sub-continental countries: A systematic review and meta-analysis.
     PLoS One. 2023;18:e0295670.
     PubMed     Abstract available
     
     
     
139. ZHANG Y, Qu L, Pan Y, Wu Y, et al
     Predictive value of hepatitis B serological indicators for mortality among cancer survivors and validation in a gastric cancer cohort.
     PLoS One. 2023;18:e0286441.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Hepatitis is free of charge.